Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,163 | -6,970 | -32,109 | -25,383 | -18,482 |
| Depreciation Amortization | 16 | 8 | 9 | 2 | N/A |
| Accounts payable and accrued liabilities | -671 | -9 | -884 | -1,320 | -334 |
| Other Working Capital | 4,166 | 4,493 | -4,060 | -3,797 | 1,752 |
| Other Operating Activity | 5,665 | 2,363 | 12,399 | 9,962 | 6,063 |
| Operating Cash Flow | $-3,987 | $-115 | $-24,645 | $-20,535 | $-11,001 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -16 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-16 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -310 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $19,690 | $N/A | $0 | $0 | $0 |
| Beginning Cash Position | 36,194 | 36,194 | 60,855 | 60,855 | 60,855 |
| End Cash Position | 51,897 | 36,078 | 36,194 | 40,320 | 49,854 |
| Net Cash Flow | $15,703 | $-115 | $-24,662 | $-20,535 | $-11,001 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,987 | -115 | -24,645 | -20,535 | -11,001 |
| Capital Expenditure | N/A | N/A | -16 | N/A | N/A |
| Free Cash Flow | -3,987 | -115 | -24,661 | -20,535 | -11,001 |